Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients.
Sunjae BaeJiYoon B Ahn KmdCorey JosephRyan WhislerMark A SchnitzlerKrista L LentineBernard S KadoshDorry L SegevMara A McAdams-DeMarcoPublished in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Statins appear to be generally well-tolerated in kidney transplant recipients. However, statin use might be associated with slightly higher risk of post-transplant diabetes mellitus, cataract, and rhabdomyolysis.